Vimentin is a type III intermediate filament (IF) protein normally expressed in cells that develop into connective tissue, ...

They are important niches to the scientists who can now solve previously unsolvable problems, but they may not constitute ...

The UK announced the funding at the AI Action Summit in Paris where it abstained from signing a declaration on an inclusive ...

Bind Research launched to transform disordered proteins into effective drug targets <li /> UK's first not-for-profit ...

Accumulation of fat molecules is detrimental to the cell. Researchers from the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine), have made a breakthrough in ...

Caltech researchers demonstrated a new method to use light to control active matter—a kind of material made up of individual ...

What started as a breakfast meeting question has led to the awarding of new research funding from The National Eye Institute ...

The Generative AI in Drug Discovery Market was valued at USD 138.5 Million in 2023. It is expected to reach USD 1,435.0 Million by 2033, with a CAGR of 27.1% ...

在蛋白质的演化过程中，它们处于广阔的序列空间，存在着许多功能相似的蛋白质。因此，蛋白质在维持功能的同时，序列可以发生改变，这种不改变功能的序列变化被称为隐性遗传变异。尽管蛋白质在探索这一序列空间时分子功能得以保留，但其未来的进化能力可能会发生变化。隐性突变的积累会形成一种遗传背景，由于上位性，相同的突变在功能等效的蛋白质上可能会产生不同的影响。这种隐性变异和上位性决定了功能相似蛋白质中的突变是适应 ...

Researchers have discovered a new mechanism that is used by a male sex hormone essential for muscle and bone function. The findings could lead to the development of new drugs with fewer side effects, ...

Vimentin is a type III intermediate filament (IF) protein normally expressed in cells that develop into connective tissue, blood vessels, and ...